HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.

Abstract
Intracellular accumulation of calcium is thought to play an integral role in the progression of ischemic injury and cell death. We infused the calcium entry blocker, nitrendipine (1.5 micrograms/kg per min), into cats in order to investigate the importance of extracellular Ca2+ influx during hemorrhagic shock. Nitrendipine proved to be a potent hypotensive agent in sham shock cats when infused over a 4 h period (156 +/- 9 to 90 +/- 5 mm Hg) (P less than 0.01). However, in hemorrhaged animals, nitrendipine treatment maintained the post-reinfusion MABP at a significantly higher (P less than 0.01) value than untreated controls (79 +/- 5 vs. 51 +/- 4 mm Hg, respectively). Superior mesenteric artery flow (SMAF) for hemorrhaged animals treated with nitrendipine was significantly higher (9.8 +/- 1.4 ml/min per kg) (P less than 0.01) than that for untreated cats (4.2 +/- 0.4 ml/min per kg), at 2 h post reinfusion. There was no significant increase in SMAF during oligemia in the nitrendipine-treated animals. Nitrendipine was also found to significantly retard the appearance of cathepsin D in the plasma of hemorrhaged cats as well as reduce plasma proteolysis to values not significantly different from sham shock animals. Furthermore, myocardial depressant factor (MDF) activity in the plasma of nitrendipine-treated shock cats was not significantly different from sham shock animals, while the plasma MDF activity for shock cats receiving vehicle increased 3-fold (P less than 0.001). The beneficial effects for nitrendipine in hemorrhagic shock are likely due to both its vasodilator function and its ability to reduce intracellular Ca2+ accumulation during ischemia, thereby reducing disruption of cell membrane systems.
AuthorsC E Hock, J Y Su, A M Lefer
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 97 Issue 1-2 Pg. 37-46 (Jan 13 1984) ISSN: 0014-2999 [Print] Netherlands
PMID6698110 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Calcium Channel Blockers
  • Myocardial Depressant Factor
  • Peptides
  • Nitrendipine
  • Cathepsins
  • Cathepsin D
  • Nifedipine
  • Calcium
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Calcium (metabolism)
  • Calcium Channel Blockers (pharmacology)
  • Cathepsin D
  • Cathepsins (blood)
  • Cats
  • Disease Models, Animal
  • Heart Rate (drug effects)
  • Male
  • Mesenteric Arteries (physiology)
  • Myocardial Depressant Factor (blood)
  • Nifedipine (analogs & derivatives, pharmacology)
  • Nitrendipine
  • Peptides (blood)
  • Regional Blood Flow (drug effects)
  • Shock, Hemorrhagic (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: